A Year in Review
An additional Day
Hospital opened
12.11.20
Sydney CBD
Total domestic
stimulated cycles
36.6%
on FY20 (FY21; 9,808)
New patient
stimulated cycles
40%
Ultrasound
scans
12.9%
on FY20 (FY21; 92,776)
Non-invasive
Pre Natal Testing
17.8%
on FY20 (FY21; 15,877)
Total Group
IVF treatments
32.5%
on FY20 (FY21; 19,733)
Pregnancy
Rates
Improved by
4.5%
since 2018
Engagement –
Culture of Success
61%
NPS
score
+61%
up from 58.5% in 2020
12 New Fertility Specialists
joined Monash IVF Group in FY21 through recruitment, as well as through our internal training program.
Revenue
$183.6m
26.3% on FY20
Adjusted NPAT 1,2,3
$23.3m
61.5% on FY20
Adjusted EBITDA 1,2
$47.7m
37.1% on FY20
Adjusted EBIT 1,2
$34.8m
42.6% on FY20
Reported NPAT 3
$25.5m
116.9% on FY20
Reported EBITDA 1
$51.3m
56.2% on FY20
1. Non-IFRS measure
2. Refer to page 29 for reconciliation of Reported EBITDA, EBIT and NPAT to Adjusted EBITDA, EBIT and NPAT
3. NPAT including minority interest